Skip to main content

Table 2 Recommendations from MGTB, N = 40

From: “A rising tide lifts all boats”: establishing a multidisciplinary genomic tumor board for breast cancer patients with advanced disease

Recommendation Number of Patients % Number of Patients who followed MGTB recommendations %
Genetics consultation 15 38 3 20
Clinical trial 34 85 6 18
FDA-approved therapies     
• On-label 13 33 5 38
• Off-label 0 0 0 0
Additional testing/biopsy     
• Androgen receptor testing 5 12 5 100
• Repeat HER2 testing 2 5 2 100